Abstract:Plants make complex and potent therapeutic molecules, but difficulties in sourcing from natural producers or chemical synthesis can challenge their use in the clinic. A prominent example is the anti-cancer therapeutic paclitaxel (Taxol ). Identification of the full paclitaxel biosynthetic pathway would enable heterologous drug production, but it has eluded discovery despite a half century of intensive research. Within the search space of ' large, enzyme-rich genome, we suspected the complex paclitaxel pathway would be difficult to resolve using conventional gene co-expression analysis and small sample sets. To improve the resolution of gene set identification, we developed a multiplexed perturbation strategy to transcriptionally profile cell states spanning tissues, cell types, developmental stages, and elicitation conditions. This approach revealed a set of paclitaxel biosynthetic genes that segregate into expression modules that suggest consecutive biosynthetic sub-pathways. These modules resolved seven new genes that, when combined with previously known enzymes, are sufficient for the biosynthesis of baccatin III, an industrial precursor for Taxol, in leaves at levels comparable to the natural abundance in needles. Included are taxane 1β-hydroxylase (T1βH), taxane 9α-hydroxylase (T9αH), taxane 7β-O-acyltransferase (T7AΤ), taxane 7β-O-deacetylase (T7dA), taxane 9α-O-deacetylase (T9dA), and taxane 9-oxidase (T9ox). Importantly, the T9αH we discovered is distinct and independently evolved from those recently reported, which failed to yield baccatin III with downstream enzymes. Unexpectedly, we also found a nuclear transport factor 2 (NTF2)-like protein (FoTO1) crucial for high yields of taxanes; this gene promotes the formation of the desired product during the first taxane oxidation step, resolving a longstanding bottleneck in paclitaxel pathway reconstitution. Together with a new β-phenylalanine-CoA-ligase, the eight genes discovered in this study enables the complete reconstitution of 3'-N-debenzoyl-2'-deoxy-paclitaxel with a 20-enzyme pathway in plants. More broadly, we establish a generalizable approach for pathway discovery that scales the power of co-expression studies to match the complexity of specialized metabolism, enabling discovery of gene sets responsible for high-value biological functions.

Six enzymes from mayapple that complete the biosynthetic pathway to the etoposide aglycone

In Vitro Reconstruction and Analysis of Evolutionary Variation of the Tomato Acylsucrose Metabolic Network

Synthesis of (−)−deoxypodophyllotoxin and (−)−epipodophyllotoxin via a multi-enzyme cascade in E. coli

Multiplexed perturbation of yew reveals cryptic proteins that enable a total biosynthesis of baccatin III and Taxol precursors

Intricate Metabolic Network for Paclitaxel Biosynthesis

Plants against cancer: towards green Taxol production through pathway discovery and metabolic engineering

Biosynthesis of the highly oxygenated tetracyclic core skeleton of Taxol

Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli

Recent Advances in Metabolic Engineering, Protein Engineering, and Transcriptome-Guided Insights Toward Synthetic Production of Taxol

Mechanistic analysis of carbon–carbon bond formation by deoxypodophyllotoxin synthase

Discovery and engineering of colchicine alkaloid biosynthesis

Review on Biosynthesis of Podophyllotoxin

Reassembly of the Biosynthetic Gene Cluster Enables High Epothilone Yield in Engineered Schlegelella Brevitalea.

Enhancing the biosynthesis of taxadien-5α-yl-acetate in Escherichia coli by combinatorial metabolic engineering approaches

Cytochrome P450 oxygenases of Taxol biosynthesis

Reconstitution of early paclitaxel biosynthetic network

Tools of pathway reconstruction and production of economically relevant plant secondary metabolites in recombinant microorganisms

Divergent camptothecin biosynthetic pathway in Ophiorrhiza pumila

Taxol Biosynthesis and Molecular Genetics

High-throughput sequencing analysis of Euphorbia fischeriana Steud provides insights into the molecular mechanism of pharmaceutical ingredient biosynthesis

An Enzymatic Strategy for the Selective Methylation of High-Value-Added Tetrahydroprotoberberine Alkaloids